Both in Pharmaceuticals
Spero Therapeutics vs Fortress Biotech
Over the past year SPRO returned −50.8% and FBIO returned −23.4%; their daily moves had a correlation of -0.00.
SPRO −50.8% FBIO −23.4%Growth of $1, one year, split-adjusted
| Metric | SPRO | FBIO |
|---|---|---|
| Price | $1.17 | $1.96 |
| Market cap | $68.1M | $65.4M |
| Today | +2.63% | +1.55% |
| 1 month | −2.5% | −10.9% |
| 6 months | −53.8% | −11.7% |
| Year to date | −49.8% | −46.4% |
| 1 year | −48.9% | −23.7% |
| Revenue growth (YoY) | −100.0% | +14.0% |
| Gross margin | — | 67.2% |
| Net margin | — | −13.2% |
| P/E (TTM) | 9.2× | 0.6× |
| Price / sales | 1.4× | 0.9× |
| Net cash | $50.7M | $157.0M |
| Dividend yield | — | — |
| Volatility (60d) | 57.4% | 45.0% |
| Short % of float | 2.0% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).